Fifth Third Bancorp Has $4.62 Million Stock Holdings in iShares Biotechnology ETF $IBB

Fifth Third Bancorp boosted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 106.4% in the 1st quarter, Holdings Channel.com reports. The firm owned 27,352 shares of the financial services provider’s stock after purchasing an additional 14,097 shares during the quarter. Fifth Third Bancorp’s holdings in iShares Biotechnology ETF were worth $4,618,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in IBB. Dynamic Wealth Strategies LLC lifted its holdings in shares of iShares Biotechnology ETF by 16.6% during the fourth quarter. Dynamic Wealth Strategies LLC now owns 422 shares of the financial services provider’s stock worth $71,000 after buying an additional 60 shares during the last quarter. Flagship Private Wealth LLC grew its stake in shares of iShares Biotechnology ETF by 2.0% in the fourth quarter. Flagship Private Wealth LLC now owns 3,084 shares of the financial services provider’s stock worth $521,000 after acquiring an additional 60 shares during the last quarter. Larson Financial Group LLC grew its stake in shares of iShares Biotechnology ETF by 2.3% in the fourth quarter. Larson Financial Group LLC now owns 2,717 shares of the financial services provider’s stock worth $458,000 after acquiring an additional 60 shares during the last quarter. Webster Bank N. A. increased its position in iShares Biotechnology ETF by 1.0% during the fourth quarter. Webster Bank N. A. now owns 6,476 shares of the financial services provider’s stock worth $1,093,000 after acquiring an additional 62 shares during the period. Finally, Choreo LLC increased its position in iShares Biotechnology ETF by 2.2% during the fourth quarter. Choreo LLC now owns 3,043 shares of the financial services provider’s stock worth $514,000 after acquiring an additional 65 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.1%

NASDAQ:IBB opened at $189.76 on Friday. iShares Biotechnology ETF has a one year low of $128.84 and a one year high of $199.05. The company has a fifty day moving average price of $177.79 and a 200 day moving average price of $173.40.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were given a dividend of $0.0238 per share. The ex-dividend date of this dividend was Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a dividend yield of 0.1%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.